Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 41.0256
Technical Avoid
1M -13.916% 6M 55.499% 1Y 44.901%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#46
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.3677
Technical Avoid
1M -14.576% 6M 12.038% 1Y -22.529%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#47
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.0377
Technical Avoid
1M -5.468% 6M 30.134% 1Y -21.014%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#48
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 24.9391
Technical Momentum
1M 21.461% 6M 83.069% 1Y 379.245%
Confidence100%
Low leverage (D/E)No promoter pledge
#49
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health85/100
Valuation 80/100 · PB 1.3763
Technical Avoid
1M -4.072% 6M 5.902% 1Y -8.717%
Confidence100%
Low leverage (D/E)No promoter pledge
#50
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.2447
Technical Avoid
1M -9.575% 6M -12.095% 1Y -45.98%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#51
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.1058
Technical Avoid
1M -8.58% 6M -15.506% 1Y -9.97%
Confidence100%
No promoter pledgeHealthy profit margins
#52
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 40/100 · PB 3.3044
Technical Avoid
1M 4.623% 6M -4.712% 1Y 38.885%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#53
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.9294
Technical Avoid
1M -4.947% 6M 0.808% 1Y -10.978%
Confidence100%
No promoter pledgeHealthy profit margins
#54
View details ➜
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 8.6245
Technical Momentum
1M 17.403% 6M 36.965% 1Y 23.022%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.5727
Technical Avoid
1M -0.675% 6M 43.36% 1Y -7.873%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#56
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.9418
Technical Avoid
1M -7.376% 6M -1.396% 1Y -10.137%
Confidence100%
Low leverage (D/E)No promoter pledge
#57
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.782
Technical Avoid
1M -5.366% 6M 29.085% 1Y -5.037%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#58
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#59
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 80/100 · PB 1.3051
Technical Avoid
1M 1.143% 6M 29.278% 1Y -37.095%
Confidence100%
Low leverage (D/E)No promoter pledge
#60
View details ➜
Showing 46 to 60 of 260 (18 Pages)